Market Pulse
Director dealings: Gfinity CEO ups stake
Gfinity revealed on Monday that chief executive David Halley had acquired 200. 0m ordinary shares in the AIM-listed eSports business.
London close: Stocks mixed as oil prices continue rising
London's stock markets ended Monday on a mixed note, as the ongoing conflict in the Middle East pushed oil prices higher, benefiting energy stocks.
FTSE 100 movers: Oil giants gush higher, NatWest jumps
London’s FTSE 100 was up 0. 3% at 8,303. 60 in afternoon trade on Monday.
US open: Stocks lower as investors look ahead to Q3 earnings
Wall Street stocks were in the red early on Monday as major indices fell short of picking up where they left off in the previous session.
Apollo to buy Barnes Group in $3.6bn deal
Technology and aerospace manufacturer Barnes Group said on Monday that it has agreed to be bought by Apollo Global Management for $3. 6bn in cash.
Sosandar signs lease in Cardiff for fourth store
Women’s fashion brand Sosandar announced the signing of a lease for its fourth store on Monday, in Cardiff's St David's shopping centre.
Futura Medical due $5m milestone payment from Haleon
Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
Chevron Canada to sell assets to Canadian Natural for $6.5bn
Chevron Canada said on Monday that it has agreed to sell its 20% interest in the Athabasca Oil Sands Project (AOSP) to Canadian Natural Resources for $6. 5bn in cash.
Cora reports positive analysis results from Tambir gold anomaly
Cora Gold reported positive results from multi-element analysis on Monday, following its recent reconnaissance drilling programme at the Tambor gold anomaly in the Madina Foulbé exploration permit area, eastern Senegal.
US pre-open: Futures points to losses as traders look ahead to Q3 earnings season
Wall Street futures were in the red ahead of the bell on Monday as major indices looked set to fall short of picking up where they left off in the previous session as investors look ahead to the beginning of Q3 earnings season later in the week.
BP abandons oil and gas output target - report
BP has abandoned a target to cut oil and gas output by 2030 as chief executive Murray Auchincloss scales back the firm's energy transition strategy to regain investor confidence, according to three sources cited by Reuters.
London midday: Stocks turn up as energy issues gain
London stocks had turned higher by midday on Monday, with energy issues providing a boost as the conflict in the Middle East lifted oil prices, and as investors mulled another uptick in UK house prices.
Applied Nutrition confirms London IPO later this month
Applied Nutrition confirmed on Monday that it plans to float on the London Stock Exchange this month.
Corero Network Security Q3 new orders total $6m
Cybersecurity firm Corero Network Security said on Monday that it has experience continued new customer momentum in Q3, with total orders in the quarter reaching $6. 0m.
Serabi releases updated Coringa economic assessment
Serabi Gold released an updated preliminary economic assessment (PEA) for its wholly-owned Coringa Gold Project in Brazil’s Para state on Monday, including improved project economics.
Vast Resources now expecting sales proceeds later in October
Mining company Vast Resources updated the market on its short-term funding situation on Monday, saying that it now expected to receive proceeds from sales around the third week of October, helping to address its immediate financial requirements.
Solid State wins 'two significant contracts' in US defence sector
Value-added components supplier Solid State has been awarded "two significant contracts" with a combined value of $5. 1m from two leading defence prime contractors for battery packs to be used in the US defence sector.
AstraZeneca enters into exclusive license agreement with CSPC
Drugmaker AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical to advance the development of a pre-clinical novel lipid-lowering therapy.
hVIVO upbeat on positive human challenge trial results with client
Specialist contract research organisation hVIVO announced positive results from a phase 2a human challenge trial (HCT) for Enanta Pharmaceuticals' RSV antiviral candidate, EDP-323, on Monday.
Asia report: Most markets rise ahead of regional rate decisions
Asian markets mostly advanced on Monday, with Japan leading gains as investors anticipated key central bank decisions later in the week.